ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...

VectorY Therapeutics receives US FDA clearance to proceed with PIONEER-ALS phase 1/2 clinical trial of VTx-002: Amsterdam Friday, December 5, 2025, 18:00 Hrs [IST] VectorY Therape ...

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with ...

Program deemed safe-to-proceed in Brazil with the first dosing expected within the next few monthsPHILADELPHIA, Nov. 24, 2025 ...

The antibody is designed to target toxic forms of TDP-43 selectively, aiming to restore normal nuclear function.

CBSE Class 12 Maths Important Questions 2026: CBSE Class 12 Board Exams 2026 are approaching, and students are now focused on ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved dosing in Cohort 8 of ENDEAVOR ...

The FDA recently removed non-ambulatory Duchenne patients from the gene therapy's indication, which Sarepta hopes to have reinstated.

Quantum computers require extreme cooling, and current cryogenic systems make quantum data centers expensive, energy-heavy, ...

Pinecone is the creator of an advanced vector database that can dynamically store, transform and index billions of ...

Despite the aggressive cost claims and dramatic scale improvements, AWS is positioning S3 Vectors as a complementary storage ...

Karthik Ramgopal highlights LinkedIn’s AI roadmap, including Hiring Assistant, personalised recommendations, and India’s ...